Evaluation of the Steelex M600H coagulometer prothrombin time-international normalized ratio assay with Steelex test reagents

Introduction The aim of the present study was to validate prothrombin time (PT) international normalized ratio (INR) results obtained using Steelex test reagents and a Steelex coagulometer (Steelex Scientific Instrument Company, Beijing, China), in comparison with use of a well-established standard test employing Pacific Hemostasis reagents (Fisher Diagnostics, Middletown, VA, USA) and Teco Coatron A4 coagulometer (Teco Medical Instruments GmbH, Neufahrn, Germany). Materials and methods: Between- and within-day coefficients of variation (CVs) of both assays were calculated using control samples provided by the test manufacturers. Samples from 90 subjects were collected and INR values were determined in a double-blind parallel manner employing both systems. Results: The within-day coefficients of variation (CVs) in INR estimates ranged from 2.6% (INR = 1.12) to 3.1% (INR = 2.51) for the Steelex system and from 2.1% (INR = 1.09) to 1.8% (INR = 2.8) for the Pacific test; the between-day values ran from 3.4% (INR = 1.16) to 7.9% (INR = 2.64) and from 3.3% (INR = 1.1) to 2.3% (INR = 2.7), respectively. Passing-Bablok fit of the of the Steelex and Pacific methods yielded the equation: Steelex INR = 0.85 (0.79–0.91) × Pacific INR + 0.12 (−0.02–0.21), whereas the CUSUM linearity P value was < 0.01. The mean bias as determined by the Bland-Altman test was −0.156 (−0.912–0.600). Conclusion: The results obtained using Steelex reagents and the M600H coagulometer are not equivalent to those obtained using Pacific Hemostasis reagents and a Teco Coatron A4 coagulometer, at least in the therapeutic range.

[1]  T. Christensen Self-management of oral anticoagulation therapy--methodological and clinical aspects. , 2011, Danish medical bulletin.

[2]  L. Bilić-Zulle,et al.  Comparison of methods: Passing and Bablok regression. , 2011, Biochemia medica.

[3]  Oswald Sonntag,et al.  Quality in the analytical phase , 2010 .

[4]  Virtudes Alvarez,et al.  Application of biological variation - a review , 2009 .

[5]  E. Favaloro,et al.  Standardization of the INR: how good is your laboratory's INR and can it be improved? , 2008, Seminars in thrombosis and hemostasis.

[6]  W. Chandler,et al.  Laboratory reporting of the international normalized ratio: progress and problems. , 2007, Archives of pathology & laboratory medicine.

[7]  Craig M Jackson,et al.  Has the time arrived to replace the quick prothrombin time test for monitoring oral anticoagulant therapy? , 2005, Clinical chemistry.

[8]  J. Vilpo,et al.  Poor agreement among prothrombin time international normalized ratio methods: comparison of seven commercial reagents. , 2005, Clinical chemistry.

[9]  L. Poller,et al.  International Normalized Ratios (INR): the first 20 years , 2004, Journal of thrombosis and haemostasis : JTH.

[10]  T. Lindahl,et al.  A Critical Evaluation of the Prothrombin Time for Monitoring Oral Anticoagulant Therapy , 2003, Pathophysiology of Haemostasis and Thrombosis.

[11]  J. Horsti Comparison of Quick and Owren Prothrombin Time with Regard to the Harmonisation of the International Normalised Ratio (INR) System , 2002, Clinical chemistry and laboratory medicine.

[12]  C Ricós,et al.  Current databases on biological variation: pros, cons and progress. , 1999, Scandinavian journal of clinical and laboratory investigation.

[13]  R. White,et al.  College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy. , 1998, Archives of pathology & laboratory medicine.

[14]  P. H. Petersen,et al.  Biological variation of International Normalized Ratio for prothrombin times, and consequences in monitoring oral anticoagulant therapy: computer simulation of serial measurements with goal-setting for analytical quality. , 1997, Clinical chemistry.

[15]  A. Goguel,et al.  Long-term French experience in INR standardization by a procedure using plasma calibrants. , 1997, American journal of clinical pathology.

[16]  I. Brandslund,et al.  Interpretation of serial measurements of international normalized ratio for prothrombin times in monitoring oral anticoagulant therapy. , 1995, Clinical chemistry.

[17]  J. Hirsh,et al.  The value of plasma calibrants in correcting coagulometer effects on international normalized ratios. An international multicenter study. , 1995, American journal of clinical pathology.

[18]  I. Brandslund,et al.  International normalized ratio for prothrombin times in patients taking oral anticoagulants: critical difference and probability of significant change in consecutive measurements. , 1995, Clinical chemistry.

[19]  J. Olson,et al.  The reliability of manufacturer-determined, instrument-specific international sensitivity index values for calculating the international normalized ratio. , 1994, American journal of clinical pathology.

[20]  E. Gottfried,et al.  Failure of the International Normalized Ratio to generate consistent results within a local medical community. , 1993, American journal of clinical pathology.

[21]  R. Peters,et al.  Determination of the Mean Normal Prothrombin Time for Assessment of International Normalized Ratios , 1991, Thrombosis and Haemostasis.

[22]  N. A. Schmidt,et al.  Correction of instrument- and reagent-based differences in determination of the International Normalized Ratio (INR) for monitoring anticoagulant therapy. , 1989, Clinical chemistry.

[23]  D A Taberner,et al.  Effect of international sensitivity index (ISI) of thromboplastins on precision of international normalised ratios (INR) , 1989, Journal of clinical pathology.

[24]  INTERNATIONAL COMMITTEE FOR STANDARDISATION IN HAEMATOLOGY: STANDARD FOR SERUM FERRITIN ASSAY , 1986, The Lancet.

[25]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[26]  J O Westgard,et al.  Criteria for judging precision and accuracy in method development and evaluation. , 1974, Clinical chemistry.

[27]  E. Loeliger ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control , 2004, Blut.

[28]  E. Loeliger International Committee for Standardization in Haematology International Committee on Thrombosis and Haemostasis , 1985, Thrombosis and Haemostasis.